↓ Skip to main content

Transcription Factor C/EBP Homologous Protein in Health and Diseases

Overview of attention for article published in Frontiers in immunology, November 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
2 X users
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
157 Dimensions

Readers on

mendeley
139 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Transcription Factor C/EBP Homologous Protein in Health and Diseases
Published in
Frontiers in immunology, November 2017
DOI 10.3389/fimmu.2017.01612
Pubmed ID
Authors

Yuan Yang, Lian Liu, Ishan Naik, Zachary Braunstein, Jixin Zhong, Boxu Ren

Abstract

C/EBP homologous protein (CHOP), known also as DNA damage-inducible transcript 3 and as growth arrest and DNA damage-inducible protein 153 (GADD153), is induced in response to certain stressors. CHOP is universally acknowledged as a main conduit to endoplasmic reticulum stress-induced apoptosis. Ongoing research established the existence of CHOP-mediated apoptosis signaling networks, for which novel downstream targets are still being determined. However, there are studies that contradict this notion and assert that apoptosis is not the only mechanism by which CHOP plays in the development of pathologies. In this review, insights into the roles of CHOP in pathophysiology are summarized at the molecular and cellular levels. We further focus on the newest advances that implicate CHOP in human diseases including cancer, diabetes, neurodegenerative disorders, and notably, fibrosis.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 139 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 139 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 32 23%
Student > Master 15 11%
Researcher 14 10%
Student > Bachelor 13 9%
Student > Doctoral Student 4 3%
Other 15 11%
Unknown 46 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 39 28%
Agricultural and Biological Sciences 15 11%
Medicine and Dentistry 14 10%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Neuroscience 6 4%
Other 13 9%
Unknown 45 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2022.
All research outputs
#7,963,683
of 25,382,440 outputs
Outputs from Frontiers in immunology
#9,543
of 31,537 outputs
Outputs of similar age
#145,486
of 446,465 outputs
Outputs of similar age from Frontiers in immunology
#235
of 596 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 31,537 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,465 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 596 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.